Dolutegravir / abacavir / lamivudine


( Last Updated : July 31, 2014)
Generic Name:
Dolutegravir / abacavir / lamivudine
Project Status:
Complete
Therapeutic Area:
HIV Infection
Manufacturer:
ViiV Healthcare
Call for patient/clinician input open:
Brand Name:
Triumeq
Project Line:
Reimbursement Review
Project Number:
SR0387-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
HIV Infection
Recommendation Type:
List with criteria/condition
Final Recommendation: